| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |